APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cytotoxicity Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cytotoxicity Testing Services Market Analysis and Forecast 2026-2032

12 August 2026189 pages

Choose your research edition.

Industry ResearchCytotoxicity Testing Services Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cytotoxicity Testing Services Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Cytotoxicity Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cytotoxicity Testing Services Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Cytotoxicity Testing Services Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

The global Cytotoxicity Testing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cytotoxicity Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cytotoxicity Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cytotoxicity Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cytotoxicity Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cytotoxicity Testing Services include Sartorius, Eurofins Scientific, TÜV SÜD, Nelson Labs, Pacific BioLabs, Emery Pharma, UFAG Laboratorien AG, NorthEast BioLab and Biosafe Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cytotoxicity Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cytotoxicity Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Cytotoxicity Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cytotoxicity Testing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cytotoxicity Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cytotoxicity Testing Services revenue, projected growth trends, production technology, application and end-user industry.

Cytotoxicity Testing Services Segment by Company

Sartorius

Eurofins Scientific

TÜV SÜD

Nelson Labs

Pacific BioLabs

Emery Pharma

UFAG Laboratorien AG

NorthEast BioLab

Biosafe Ltd

Creative Bioarray

Evercyte

IONTOX

Applied StemCell

Xenometrix AG

Medicilon

UL

SGS

iuvo BioScience

Cytotoxicity Testing Services Segment by Type

Elution Testing Method

Agar Overlay Method

Direct Contact Method

MTT Assay Method

Others

Cytotoxicity Testing Services Segment by Application

Drug

Medical Instruments

Cosmetics and Personal Care

Others

Cytotoxicity Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cytotoxicity Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cytotoxicity Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cytotoxicity Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cytotoxicity Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cytotoxicity Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytotoxicity Testing Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cytotoxicity Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Elution Testing Method Major Player Table 3. Agar Overlay Method Major Player Table 4. Direct Contact Method Major Player Table 5. MTT Assay Method Major Player Table 6. Others Major Player Table 7. Global Cytotoxicity Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Drug Major Player Table 9. Medical Instruments Major Player Table 10. Cosmetics and Personal Care Major Player Table 11. Others Major Player Table 12. Cytotoxicity Testing Services Industry Trends Table 13. Cytotoxicity Testing Services Industry Drivers Table 14. Cytotoxicity Testing Services Industry Opportunities and Challenges Table 15. Cytotoxicity Testing Services Industry Restraints Table 16. Global Cytotoxicity Testing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Cytotoxicity Testing Services Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Cytotoxicity Testing Services Market Share by Region (2021-2026) Table 19. Global Cytotoxicity Testing Services Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Cytotoxicity Testing Services Market Share by Region (2027-2032) Table 21. Global Cytotoxicity Testing Services Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Cytotoxicity Testing Services Revenue Market Share by Players (2021-2026) Table 23. Global Cytotoxicity Testing Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Cytotoxicity Testing Services Key Players Headquarters & Area Served Table 25. Global Cytotoxicity Testing Services Players, Product Type & Application Table 26. Global Cytotoxicity Testing Services Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Cytotoxicity Testing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Cytotoxicity Testing Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cytotoxicity Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Cytotoxicity Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Cytotoxicity Testing Services Revenue Market Share by Type (2021-2026) Table 33. Global Cytotoxicity Testing Services Revenue Market Share by Type (2027-2032) Table 34. Global Cytotoxicity Testing Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cytotoxicity Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Cytotoxicity Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Cytotoxicity Testing Services Revenue Market Share by Application (2021-2026) Table 38. Global Cytotoxicity Testing Services Revenue Market Share by Application (2027-2032) Table 39. Sartorius Company Information Table 40. Sartorius Business Overview Table 41. Sartorius Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Sartorius Cytotoxicity Testing Services Product Portfolio Table 43. Sartorius Recent Development Table 44. Eurofins Scientific Company Information Table 45. Eurofins Scientific Business Overview Table 46. Eurofins Scientific Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Eurofins Scientific Cytotoxicity Testing Services Product Portfolio Table 48. Eurofins Scientific Recent Development Table 49. TÜV SÜD Company Information Table 50. TÜV SÜD Business Overview Table 51. TÜV SÜD Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. TÜV SÜD Cytotoxicity Testing Services Product Portfolio Table 53. TÜV SÜD Recent Development Table 54. Nelson Labs Company Information Table 55. Nelson Labs Business Overview Table 56. Nelson Labs Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Nelson Labs Cytotoxicity Testing Services Product Portfolio Table 58. Nelson Labs Recent Development Table 59. Pacific BioLabs Company Information Table 60. Pacific BioLabs Business Overview Table 61. Pacific BioLabs Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Pacific BioLabs Cytotoxicity Testing Services Product Portfolio Table 63. Pacific BioLabs Recent Development Table 64. Emery Pharma Company Information Table 65. Emery Pharma Business Overview Table 66. Emery Pharma Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Emery Pharma Cytotoxicity Testing Services Product Portfolio Table 68. Emery Pharma Recent Development Table 69. UFAG Laboratorien AG Company Information Table 70. UFAG Laboratorien AG Business Overview Table 71. UFAG Laboratorien AG Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. UFAG Laboratorien AG Cytotoxicity Testing Services Product Portfolio Table 73. UFAG Laboratorien AG Recent Development Table 74. NorthEast BioLab Company Information Table 75. NorthEast BioLab Business Overview Table 76. NorthEast BioLab Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. NorthEast BioLab Cytotoxicity Testing Services Product Portfolio Table 78. NorthEast BioLab Recent Development Table 79. Biosafe Ltd Company Information Table 80. Biosafe Ltd Business Overview Table 81. Biosafe Ltd Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Biosafe Ltd Cytotoxicity Testing Services Product Portfolio Table 83. Biosafe Ltd Recent Development Table 84. Creative Bioarray Company Information Table 85. Creative Bioarray Business Overview Table 86. Creative Bioarray Cytotoxicity Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Creative Bioarray Cytotoxicity Testing Services Product Portfolio Table 88. Creative Bioarray Recent Development Table 89. Evercyte Company Information Table 90. Evercyte Business Overview Table 91. Evercyte Cytotoxicity Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Evercyte Cytotoxicity Testing Services Product Portfolio Table 93. Evercyte Recent Development Table 94. IONTOX Company Information Table 95. IONTOX Business Overview Table 96. IONTOX Cytotoxicity Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. IONTOX Cytotoxicity Testing Services Product Portfolio Table 98. IONTOX Recent Development Table 99. Applied StemCell Company Information Table 100. Applied StemCell Business Overview Table 101. Applied StemCell Cytotoxicity Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Applied StemCell Cytotoxicity Testing Services Product Portfolio Table 103. Applied StemCell Recent Development Table 104. Xenometrix AG Company Information Table 105. Xenometrix AG Business Overview Table 106. Xenometrix AG Cytotoxicity Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Xenometrix AG Cytotoxicity Testing Services Product Portfolio Table 108. Xenometrix AG Recent Development Table 109. Medicilon Company Information Table 110. Medicilon Business Overview Table 111. Medicilon Cytotoxicity Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Medicilon Cytotoxicity Testing Services Product Portfolio Table 113. Medicilon Recent Development Table 114. UL Company Information Table 115. UL Business Overview Table 116. UL Cytotoxicity Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. UL Cytotoxicity Testing Services Product Portfolio Table 118. UL Recent Development Table 119. SGS Company Information Table 120. SGS Business Overview Table 121. SGS Cytotoxicity Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. SGS Cytotoxicity Testing Services Product Portfolio Table 123. SGS Recent Development Table 124. iuvo BioScience Company Information Table 125. iuvo BioScience Business Overview Table 126. iuvo BioScience Cytotoxicity Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. iuvo BioScience Cytotoxicity Testing Services Product Portfolio Table 128. iuvo BioScience Recent Development Table 129. North America Cytotoxicity Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Cytotoxicity Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Cytotoxicity Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Cytotoxicity Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Cytotoxicity Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Cytotoxicity Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 135. North America Cytotoxicity Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 136. Europe Cytotoxicity Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Cytotoxicity Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Cytotoxicity Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Cytotoxicity Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Cytotoxicity Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Cytotoxicity Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 142. Europe Cytotoxicity Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 143. China Cytotoxicity Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 144. China Cytotoxicity Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 145. China Cytotoxicity Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 146. China Cytotoxicity Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Cytotoxicity Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Cytotoxicity Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Cytotoxicity Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Cytotoxicity Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Cytotoxicity Testing Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Cytotoxicity Testing Services Revenue by Region (US$ Million) & (2021-2026) Table 153. Asia Cytotoxicity Testing Services Revenue by Region (US$ Million) & (2027-2032) Table 154. SAMEA Cytotoxicity Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Cytotoxicity Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Cytotoxicity Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 157. SAMEA Cytotoxicity Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 158. SAMEA Cytotoxicity Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. SAMEA Cytotoxicity Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 160. SAMEA Cytotoxicity Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Cytotoxicity Testing Services Image Figure 2. Global Cytotoxicity Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cytotoxicity Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Elution Testing Method Image Figure 5. Agar Overlay Method Image Figure 6. Direct Contact Method Image Figure 7. MTT Assay Method Image Figure 8. Others Image Figure 9. Global Cytotoxicity Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Cytotoxicity Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 11. Drug Image Figure 12. Medical Instruments Image Figure 13. Cosmetics and Personal Care Image Figure 14. Others Image Figure 15. Global Cytotoxicity Testing Services Market Size (US$ Million) & (2021-2032) Figure 16. Global Cytotoxicity Testing Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Cytotoxicity Testing Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Cytotoxicity Testing Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Cytotoxicity Testing Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cytotoxicity Testing Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Cytotoxicity Testing Services Revenue Market Share by Type (2021-2032) Figure 23. Global Cytotoxicity Testing Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cytotoxicity Testing Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Cytotoxicity Testing Services Revenue Market Share by Application (2021-2032) Figure 26. North America Cytotoxicity Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Cytotoxicity Testing Services Revenue Share by Type (2021-2032) Figure 28. North America Cytotoxicity Testing Services Revenue Share by Application (2021-2032) Figure 29. North America Cytotoxicity Testing Services Revenue Share by Country (2021-2032) Figure 30. United States Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Cytotoxicity Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Cytotoxicity Testing Services Revenue Share by Type (2021-2032) Figure 35. Europe Cytotoxicity Testing Services Revenue Share by Application (2021-2032) Figure 36. Europe Cytotoxicity Testing Services Revenue Share by Country (2021-2032) Figure 37. Germany Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Cytotoxicity Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Cytotoxicity Testing Services Revenue Share by Type (2021-2032) Figure 47. China Cytotoxicity Testing Services Revenue Share by Application (2021-2032) Figure 48. Asia Cytotoxicity Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Cytotoxicity Testing Services Revenue Share by Type (2021-2032) Figure 50. Asia Cytotoxicity Testing Services Revenue Share by Application (2021-2032) Figure 51. Asia Cytotoxicity Testing Services Revenue Share by Region (2021-2032) Figure 52. Japan Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Cytotoxicity Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Cytotoxicity Testing Services Revenue Share by Type (2021-2032) Figure 60. SAMEA Cytotoxicity Testing Services Revenue Share by Application (2021-2032) Figure 61. SAMEA Cytotoxicity Testing Services Revenue Share by Country (2021-2032) Figure 62. Brazil Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Cytotoxicity Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Elution Testing Method
  • Agar Overlay Method
  • Direct Contact Method
  • MTT Assay Method
  • Others
Applications
  • Drug
  • Medical Instruments
  • Cosmetics and Personal Care
  • Others
Companies covered
  • Sartorius
  • Eurofins Scientific
  • TÜV SÜD
  • Nelson Labs
  • Pacific BioLabs
  • Emery Pharma
  • UFAG Laboratorien AG
  • NorthEast BioLab
  • Biosafe Ltd
  • Creative Bioarray
  • Evercyte
  • IONTOX
  • Applied StemCell
  • Xenometrix AG
  • Medicilon
  • UL
  • SGS
  • iuvo BioScience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cytotoxicity Testing Services Market by Type
  3. 1.2.1 Global Cytotoxicity Testing Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Elution Testing Method
  5. 1.2.3 Agar Overlay Method
  6. 1.2.4 Direct Contact Method
  7. 1.2.5 MTT Assay Method
  8. 1.2.6 Others
  9. 1.3 Cytotoxicity Testing Services Market by Application
  10. 1.3.1 Global Cytotoxicity Testing Services Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Drug
  12. 1.3.3 Medical Instruments
  13. 1.3.4 Cosmetics and Personal Care
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Cytotoxicity Testing Services Market Dynamics
  1. 2.1 Cytotoxicity Testing Services Industry Trends
  2. 2.2 Cytotoxicity Testing Services Industry Drivers
  3. 2.3 Cytotoxicity Testing Services Industry Opportunities and Challenges
  4. 2.4 Cytotoxicity Testing Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cytotoxicity Testing Services Market Perspective (2021-2032)
  2. 3.2 Global Cytotoxicity Testing Services Growth Trends by Region
  3. 3.2.1 Global Cytotoxicity Testing Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cytotoxicity Testing Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Cytotoxicity Testing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cytotoxicity Testing Services Revenue by Players
  2. 4.1.1 Global Cytotoxicity Testing Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Cytotoxicity Testing Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cytotoxicity Testing Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cytotoxicity Testing Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cytotoxicity Testing Services Key Players Headquarters & Area Served
  7. 4.4 Global Cytotoxicity Testing Services Players, Product Type & Application
  8. 4.5 Global Cytotoxicity Testing Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cytotoxicity Testing Services Market CR5 and HHI
  11. 4.6.3 2025 Cytotoxicity Testing Services Tier 1, Tier 2, and Tier 3
5 Cytotoxicity Testing Services Market Size by Type
  1. 5.1 Global Cytotoxicity Testing Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cytotoxicity Testing Services Revenue by Type (2021-2032)
  3. 5.3 Global Cytotoxicity Testing Services Revenue Market Share by Type (2021-2032)
6 Cytotoxicity Testing Services Market Size by Application
  1. 6.1 Global Cytotoxicity Testing Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cytotoxicity Testing Services Revenue by Application (2021-2032)
  3. 6.3 Global Cytotoxicity Testing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sartorius
  2. 7.1.1 Sartorius Company Information
  3. 7.1.2 Sartorius Business Overview
  4. 7.1.3 Sartorius Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sartorius Cytotoxicity Testing Services Product Portfolio
  6. 7.1.5 Sartorius Recent Developments
  7. 7.2 Eurofins Scientific
  8. 7.2.1 Eurofins Scientific Company Information
  9. 7.2.2 Eurofins Scientific Business Overview
  10. 7.2.3 Eurofins Scientific Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eurofins Scientific Cytotoxicity Testing Services Product Portfolio
  12. 7.2.5 Eurofins Scientific Recent Developments
  13. 7.3 TÜV SÜD
  14. 7.3.1 TÜV SÜD Company Information
  15. 7.3.2 TÜV SÜD Business Overview
  16. 7.3.3 TÜV SÜD Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 TÜV SÜD Cytotoxicity Testing Services Product Portfolio
  18. 7.3.5 TÜV SÜD Recent Developments
  19. 7.4 Nelson Labs
  20. 7.4.1 Nelson Labs Company Information
  21. 7.4.2 Nelson Labs Business Overview
  22. 7.4.3 Nelson Labs Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Nelson Labs Cytotoxicity Testing Services Product Portfolio
  24. 7.4.5 Nelson Labs Recent Developments
  25. 7.5 Pacific BioLabs
  26. 7.5.1 Pacific BioLabs Company Information
  27. 7.5.2 Pacific BioLabs Business Overview
  28. 7.5.3 Pacific BioLabs Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pacific BioLabs Cytotoxicity Testing Services Product Portfolio
  30. 7.5.5 Pacific BioLabs Recent Developments
  31. 7.6 Emery Pharma
  32. 7.6.1 Emery Pharma Company Information
  33. 7.6.2 Emery Pharma Business Overview
  34. 7.6.3 Emery Pharma Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Emery Pharma Cytotoxicity Testing Services Product Portfolio
  36. 7.6.5 Emery Pharma Recent Developments
  37. 7.7 UFAG Laboratorien AG
  38. 7.7.1 UFAG Laboratorien AG Company Information
  39. 7.7.2 UFAG Laboratorien AG Business Overview
  40. 7.7.3 UFAG Laboratorien AG Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 UFAG Laboratorien AG Cytotoxicity Testing Services Product Portfolio
  42. 7.7.5 UFAG Laboratorien AG Recent Developments
  43. 7.8 NorthEast BioLab
  44. 7.8.1 NorthEast BioLab Company Information
  45. 7.8.2 NorthEast BioLab Business Overview
  46. 7.8.3 NorthEast BioLab Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NorthEast BioLab Cytotoxicity Testing Services Product Portfolio
  48. 7.8.5 NorthEast BioLab Recent Developments
  49. 7.9 Biosafe Ltd
  50. 7.9.1 Biosafe Ltd Company Information
  51. 7.9.2 Biosafe Ltd Business Overview
  52. 7.9.3 Biosafe Ltd Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biosafe Ltd Cytotoxicity Testing Services Product Portfolio
  54. 7.9.5 Biosafe Ltd Recent Developments
  55. 7.10 Creative Bioarray
  56. 7.10.1 Creative Bioarray Company Information
  57. 7.10.2 Creative Bioarray Business Overview
  58. 7.10.3 Creative Bioarray Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Creative Bioarray Cytotoxicity Testing Services Product Portfolio
  60. 7.10.5 Creative Bioarray Recent Developments
  61. 7.11 Evercyte
  62. 7.11.1 Evercyte Company Information
  63. 7.11.2 Evercyte Business Overview
  64. 7.11.3 Evercyte Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Evercyte Cytotoxicity Testing Services Product Portfolio
  66. 7.11.5 Evercyte Recent Developments
  67. 7.12 IONTOX
  68. 7.12.1 IONTOX Company Information
  69. 7.12.2 IONTOX Business Overview
  70. 7.12.3 IONTOX Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 IONTOX Cytotoxicity Testing Services Product Portfolio
  72. 7.12.5 IONTOX Recent Developments
  73. 7.13 Applied StemCell
  74. 7.13.1 Applied StemCell Company Information
  75. 7.13.2 Applied StemCell Business Overview
  76. 7.13.3 Applied StemCell Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Applied StemCell Cytotoxicity Testing Services Product Portfolio
  78. 7.13.5 Applied StemCell Recent Developments
  79. 7.14 Xenometrix AG
  80. 7.14.1 Xenometrix AG Company Information
  81. 7.14.2 Xenometrix AG Business Overview
  82. 7.14.3 Xenometrix AG Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Xenometrix AG Cytotoxicity Testing Services Product Portfolio
  84. 7.14.5 Xenometrix AG Recent Developments
  85. 7.15 Medicilon
  86. 7.15.1 Medicilon Company Information
  87. 7.15.2 Medicilon Business Overview
  88. 7.15.3 Medicilon Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Medicilon Cytotoxicity Testing Services Product Portfolio
  90. 7.15.5 Medicilon Recent Developments
  91. 7.16 UL
  92. 7.16.1 UL Company Information
  93. 7.16.2 UL Business Overview
  94. 7.16.3 UL Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 UL Cytotoxicity Testing Services Product Portfolio
  96. 7.16.5 UL Recent Developments
  97. 7.17 SGS
  98. 7.17.1 SGS Company Information
  99. 7.17.2 SGS Business Overview
  100. 7.17.3 SGS Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 SGS Cytotoxicity Testing Services Product Portfolio
  102. 7.17.5 SGS Recent Developments
  103. 7.18 iuvo BioScience
  104. 7.18.1 iuvo BioScience Company Information
  105. 7.18.2 iuvo BioScience Business Overview
  106. 7.18.3 iuvo BioScience Cytotoxicity Testing Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 iuvo BioScience Cytotoxicity Testing Services Product Portfolio
  108. 7.18.5 iuvo BioScience Recent Developments
8 North America
  1. 8.1 North America Cytotoxicity Testing Services Revenue (2021-2032)
  2. 8.2 North America Cytotoxicity Testing Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Cytotoxicity Testing Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Cytotoxicity Testing Services Revenue by Type (2027-2032)
  5. 8.3 North America Cytotoxicity Testing Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Cytotoxicity Testing Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Cytotoxicity Testing Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Cytotoxicity Testing Services Revenue by Application (2027-2032)
  9. 8.5 North America Cytotoxicity Testing Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Cytotoxicity Testing Services Revenue by Country
  11. 8.6.1 North America Cytotoxicity Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cytotoxicity Testing Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Cytotoxicity Testing Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cytotoxicity Testing Services Revenue (2021-2032)
  2. 9.2 Europe Cytotoxicity Testing Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cytotoxicity Testing Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cytotoxicity Testing Services Revenue by Type (2027-2032)
  5. 9.3 Europe Cytotoxicity Testing Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cytotoxicity Testing Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cytotoxicity Testing Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cytotoxicity Testing Services Revenue by Application (2027-2032)
  9. 9.5 Europe Cytotoxicity Testing Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cytotoxicity Testing Services Revenue by Country
  11. 9.6.1 Europe Cytotoxicity Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cytotoxicity Testing Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cytotoxicity Testing Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cytotoxicity Testing Services Revenue (2021-2032)
  2. 10.2 China Cytotoxicity Testing Services Revenue by Type (2021-2032)
  3. 10.2.1 China Cytotoxicity Testing Services Revenue by Type (2021-2026)
  4. 10.2.2 China Cytotoxicity Testing Services Revenue by Type (2027-2032)
  5. 10.3 China Cytotoxicity Testing Services Revenue Share by Type (2021-2032)
  6. 10.4 China Cytotoxicity Testing Services Revenue by Application (2021-2032)
  7. 10.4.1 China Cytotoxicity Testing Services Revenue by Application (2021-2026)
  8. 10.4.2 China Cytotoxicity Testing Services Revenue by Application (2027-2032)
  9. 10.5 China Cytotoxicity Testing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cytotoxicity Testing Services Revenue (2021-2032)
  2. 11.2 Asia Cytotoxicity Testing Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cytotoxicity Testing Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cytotoxicity Testing Services Revenue by Type (2027-2032)
  5. 11.3 Asia Cytotoxicity Testing Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cytotoxicity Testing Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cytotoxicity Testing Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cytotoxicity Testing Services Revenue by Application (2027-2032)
  9. 11.5 Asia Cytotoxicity Testing Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cytotoxicity Testing Services Revenue by Country
  11. 11.6.1 Asia Cytotoxicity Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cytotoxicity Testing Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cytotoxicity Testing Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cytotoxicity Testing Services Revenue (2021-2032)
  2. 12.2 SAMEA Cytotoxicity Testing Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cytotoxicity Testing Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cytotoxicity Testing Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cytotoxicity Testing Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cytotoxicity Testing Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cytotoxicity Testing Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cytotoxicity Testing Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cytotoxicity Testing Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cytotoxicity Testing Services Revenue by Country
  11. 12.6.1 SAMEA Cytotoxicity Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cytotoxicity Testing Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cytotoxicity Testing Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst